Champions Oncology, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() ANTX
AN2 Therapeutics, Inc. |
$1.10 | $33.19 M | -0.73 | 22 |
![]() IPSC
Century Therapeutics, Inc. |
$0.57 | $49.39 M | -2.12 | 140 |
![]() ACRV
Acrivon Therapeutics, Inc. Common Stock |
$1.33 | $41.70 M | -0.62 | 75 |
![]() AVTE
Aerovate Therapeutics, Inc. |
$10.51 | $77.68 M | -0.05 | 4 |
![]() MNOV
MediciNova, Inc. |
$1.34 | $65.23 M | -5.78 | 13 |
![]() CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 |
![]() RZLT
Rezolute, Inc. |
$4.33 | $375.91 M | -3.73 | 64 |
![]() ADAG
Adagene Inc. |
$1.92 | $73.49 M | -2.64 | 138 |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.47 | $57.52 M | -5.6 | 2 |
![]() STTK
Shattuck Labs, Inc. |
$1.05 | $50.54 M | -0.76 | 44 |
![]() ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
![]() HCWB
HCW Biologics Inc. |
$4.45 | $10.57 M | -0.18 | 36 |
![]() MOLN
Molecular Partners AG |
$3.82 | $136.10 M | -1.77 | 158 |
![]() PRDS
Pardes Biosciences, Inc. |
$2.18 | $135.19 M | -1.7 | 57 |